hiPSC Differentiation into CD200+ Epithelial Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively isolate and propagate human epithelial stem cells (hEpSCs) for hair follicle regeneration and tissue engineering, as differentiated human induced pluripotent stem cells (hiPSCs) lose stem cell marker expression and function in vitro, and existing protocols do not successfully generate functional hair follicles.
Innovation Solution
A strategy for differentiating hiPSCs into CD200+/ITGA6+ epithelial stem cells that can reconstitute hair follicle and interfollicular epidermis components, using a sequential differentiation protocol involving BMP4, retinoic acid, and EGF, resulting in cells with high colony forming efficiency and gene expression similarity to native hEpSCs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If human induced pluripotent stem cells are differentiated into keratinocytes using existing protocols, then keratinocyte cells are generated, but the cells exhibit an epidermal squamous cell phenotype and lose the capacity to regenerate hair follicles
Solution Approach 1:
The differentiation process is segmented into distinct stages: first generating multipotent epithelial progenitor cells (MEPCs) with hair follicle regeneration capacity, then separately differentiating them into either epidermal keratinocytes or hair follicle structures. This segmentation allows preservation of stemness in the intermediate MEPC stage while enabling controlled differentiation into specific lineages.
Solution Approach 2:
The protocol performs preliminary action by first establishing MEPCs with inherent hair follicle regenerative capacity before committing to final differentiation. This preliminary MEPC stage serves as a reservoir of multipotent cells that can be directed toward different fates, ensuring the capability for hair follicle regeneration is established before terminal differentiation occurs.
2Quantity of substance
If human hair follicle epithelial stem cells are isolated and cultured in vitro, then stem cells are obtained, but they rapidly lose stem cell marker expression and function
Solution Approach 1:
The MEPCs are cultured in a defined medium containing EGF and bFGF that supports their self-renewal and maintenance of stem cell markers. The culture system provides necessary growth factors that enable the cells to service their own maintenance needs, preserving KRT15 and CD200 expression while allowing expansion of cell numbers.
Solution Approach 2:
The culture conditions are optimized with specific growth factor concentrations (EGF at 20 ng/mL, bFGF at 20 ng/mL) and serum-free formulation to maintain stem cell marker expression. These parameter changes in the culture environment prevent the rapid loss of markers that occurs in conventional keratinocyte culture systems.
3Reliability
If a sequential differentiation protocol using BMP4, retinoic acid, and EGF is applied to hiPSCs, then CD200+/ITGA6+ epithelial stem cells with high colony forming efficiency are generated, but the protocol complexity increases
Solution Approach 1:
The differentiation protocol is segmented into three distinct sequential stages with specific growth factor combinations: Stage 1 (days 0-3) uses BMP4 and retinoic acid to induce MEPC formation; Stage 2 (days 3-7) introduces EGF to expand and enrich the MEPC population; Stage 3 (days 7-14) uses EGF alone for final differentiation. This segmentation into temporally distinct phases with defined factor combinations simplifies the overall complexity while achieving high reliability.
Solution Approach 2:
The protocol maintains continuous useful action by using overlapping time periods for growth factor addition and ensuring smooth transitions between stages. EGF is introduced in Stage 2 and continues through Stage 3, providing continuous support for epithelial cell proliferation and differentiation throughout the critical expansion phase, thereby maintaining high colony forming efficiency.
Data Source
AI summary
Compositions and methods for generating human epithelial stem cells from induced pluripotent stem cells are disclosed. Also disclosed are methods of using cells so generated in hair transplant procedures.